Business
Clariant delivers strong profitability on flat local currency sales in Q2 2025
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR SECOND QUARTER/FIRST HALF YEAR | 2025 Q2 2025 sales of CHF 968 million were flat in local currencies1, as growth in Catalysts and Adsorbents & Additives offset a slight decline in Care Chemicals; stable pricing Q2 2025 EBITDA margin before exceptional items increased by 200 basis points to 17.5 % from 15.5 % in Q2 2024, driven by improvements in Catalysts and Adsorbents & Additives, while flat in Care Chemicals; reported EBITDA margin impacted by CHF 22
About this update from Clariant Ag
[{"type":"image","alt":"Clariant International Ltd","displaySize":"","headline":null,"caption":"Clariant International Ltd","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":114,"url":"https://media.zenfs.com/en/globenewswire.com/1948dabdfcb1ca27093e6679ef62df42"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FJw0HdasEAPJlpdQQNRIHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/1948dabdfcb1ca27093e6679ef62df42","width":300,"height":114}},"lazy":false},{"type":"text","content":"AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR","length":42,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:682.34px;text-align:justify;vertical-align:middle;vertical-align:top;","val":[{"type":"text","content":"SECOND QUARTER/FIRST HALF YEAR | 2025","length":37,"tagName":"p","attribs":{}}]}]}],"length":37},{"type":"list","items":[{"val":[{"type":"text","content":"Q2 2025 sales of CHF 968 million were flat in local currencies1, as growth in Catalysts and Adsorbents & Additives offset a slight decline in Care Chemicals; stable pricing ","length":191,"tagName":"p"}]},{"val":[{"type":"text","content":"Q2 2025 EBITDA margin before exceptional items increased by 200 basis points to 17.5 % from 15.5 % in Q2 2024, driven by improvements in Catalysts and Adsorbents & Additives, while flat in Care Chemicals; reported EBITDA margin impacted by CHF 22 million restructuring charges","length":310,"tagName":"p"}]},{"val":[{"type":"text","content":"H1 2025 sales increased by 1 % in local currencies1 to CHF 1.981 billion, as growth in Care Chemicals and Adsorbents & Additives offset slightly lower Catalysts sales; pricing was up 1 %","length":215,"tagName":"p"}]},{"val":[{"type":"text","content":"H1 2025 EBITDA margin before exceptional items increased by 130 basis points to 18.1 % from 16.8 % in the prior year, driven by improvements in all business units","length":177,"tagName":"p"}]},{"val":[{"type":"text","content":"H1 2025 operating cash flow of CHF 116 million, with free cash flow conversion (LTM) of 37 %","length":107,"tagName":"p"}]},{"val":[{"type":"text","content":"Investor Day savings program of CHF 80 million well underway with CHF 12 millio...